Washington Capital Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-6,576
Closed -$550K 133
2016
Q1
$550K Sell
6,576
-1,935
-23% -$159K 0.4% 87
2015
Q4
$842K Sell
8,511
-77
-0.9% -$8.25K 0.52% 83
2015
Q3
$1.05M Buy
8,588
+356
+4% +$48.3K 0.66% 77
2015
Q2
$1.26M Hold
8,232
0.71% 69
2015
Q1
$1.41M Sell
8,232
-7,132
-46% -$1.08M 0.81% 59
2014
Q4
$2.35M Sell
15,364
-2,125
-12% -$265K 0.98% 52
2014
Q3
$1.85M Sell
17,489
-176
-1% -$24.5K 0.73% 80
2014
Q2
$2.69M Sell
17,665
-305
-2% -$40.6K 0.99% 23
2014
Q1
$2.31M Sell
17,970
-1,562
-8% -$243K 0.84% 48
2013
Q4
$3.41M Buy
19,532
+412
+2% +$70.8K 0.82% 37
2013
Q3
$3.09M Sell
19,120
-1,185
-6% -$187K 0.82% 40
2013
Q2
$2.7M Buy
+20,305
New +$2.87M 0.7% 54

Other funds holding ELGX

Washington Capital Management's ELGX Position: Q2 2016 in Review

Washington Capital Management sold out of Endologix Inc (ELGX) in Q2 2016, closing a stake of 6,576 shares — an estimated $550K sold.

Washington Capital Management first reported a position in ELGX in Q2 2013 and held it in 12 quarters. The position peaked at $3.41M in Q4 2013. 163 funds tracked by Wall St. Rank hold ELGX as of Q2 2016.

  • Washington Capital Management reported no remaining Endologix Inc position as of Q2 2016 after selling out during the quarter.
  • Washington Capital Management sold 6,576 Endologix Inc shares in Q2 2016, an estimated $550K.
  • Washington Capital Management first reported a position in Endologix Inc in Q2 2013 and held it in 12 quarters.
  • Washington Capital Management's Endologix Inc position peaked at $3.41M in Q4 2013.
  • 163 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2016.

Based on Washington Capital Management's 13F filing for Q2 2016, filed 5 Aug 2016.